CS1 targeted chimeric antigen receptor-modified T cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10821161
APP PUB NO 20170360910A1
SERIAL NO

15533153

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chimeric antigen receptors for use in treating malignant melanoma and other cancers expressing CS1 are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CITY OF HOPE1500 EAST DUARTE ROAD DUARTE CA 91010

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Forman, Stephen J Duarte, US 46 59
Wang, Xiuli Duarte, US 30 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 3, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 3, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00